Dr Anne Jones has been appointed to the position of Chief Operating Officer of Genuity Science. Since the late 2018 acquisition of Genomics Medicine Ireland (GMI) by then WuXi NextCODE, Anne served as WuXi NextCODE’s GM and site leader for Ireland and the CEO of the GMI entity. In Autumn 2019, she additionally took on global responsibility for data sourcing, data analysis and data insights, with teams in Iceland, Ireland and the U.S.
“Anne has made a significant contribution in her 20 months here, at Genuity Science,” commented Genuity Science CEO, Rob Brainin. “She’s built a positive network of relationships with our partners and collaborators, grown our research studies and has a penchant for execution and results which is what convinced me that she is well-suited for this role,” continued Brainin.
Dr Jones will continue to manager her time between Ireland and Boston, while also spending significant time in Iceland. Importantly, she will continue her role leading Genuity Science (Ireland) Ltd. working closely with Genuity Science partners and collaborators throughout Ireland and Europe.